Meng Zhou Selected Research

E2F2 Transcription Factor

11/2021

Genetic variants of cell cycle pathway genes are associated with head and neck squamous cell carcinoma in the Chinese population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Meng Zhou Research Topics

Disease

73	Neoplasms (Cancer) 01/2022 - 04/2010
12	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2013
9	Neoplasm Metastasis (Metastasis) 03/2022 - 11/2015
9	Breast Neoplasms (Breast Cancer) 02/2022 - 08/2015
9	Carcinogenesis 01/2022 - 02/2016
8	Inflammation (Inflammations) 08/2022 - 12/2017
7	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 11/2014
6	Hypoxia (Hypoxemia) 01/2022 - 05/2015
6	Alzheimer Disease (Alzheimer's Disease) 12/2016 - 08/2014
5	Leukemia 09/2021 - 06/2011
5	Stomach Neoplasms (Stomach Cancer) 01/2021 - 09/2015
4	Fibrosis (Cirrhosis) 04/2022 - 01/2015
4	Wounds and Injuries (Trauma) 01/2022 - 01/2017
4	Myocardial Infarction 01/2022 - 01/2015
4	Adenocarcinoma of Lung 07/2021 - 05/2016
4	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 06/2014
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2020 - 01/2015
3	Lymphatic Metastasis 09/2022 - 01/2021
3	Thrombosis (Thrombus) 08/2022 - 01/2022
3	Infections 07/2022 - 11/2015
3	Cardiovascular Diseases (Cardiovascular Disease) 06/2022 - 05/2018
3	Thrombotic Microangiopathies 06/2022 - 01/2020
3	Graft vs Host Disease (Graft-Versus-Host Disease) 06/2022 - 06/2020
3	Hemorrhage 02/2022 - 09/2021
3	Reperfusion Injury 10/2021 - 05/2015
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2021 - 01/2017
3	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 01/2016
3	Rheumatoid Arthritis 11/2020 - 01/2014
3	Pancreatic Neoplasms (Pancreatic Cancer) 08/2020 - 08/2016
3	Diabetic Nephropathies (Diabetic Nephropathy) 11/2019 - 01/2016
2	Myocardial Ischemia (Ischemic Heart Diseases) 08/2022 - 01/2021
2	Pulmonary Embolism 08/2022 - 01/2022
2	Colorectal Neoplasms (Colorectal Cancer) 06/2022 - 01/2021
2	Body Weight (Weight, Body) 06/2022 - 12/2017
2	Acute Kidney Injury (Acute Renal Failure) 06/2022 - 09/2016
2	Mitochondrial Diseases (Mitochondrial Disease) 06/2022 - 01/2019
2	Hyperuricemia 05/2022 - 06/2019
2	Obesity 05/2022 - 01/2021
2	Fatty Liver 04/2022 - 12/2017
2	COVID-19 02/2022 - 01/2021
2	Cytokine Release Syndrome 02/2022 - 01/2020
2	Hematologic Neoplasms (Hematological Malignancy) 02/2022 - 01/2022
2	Squamous Cell Carcinoma of Head and Neck 01/2022 - 11/2021
2	Tuberous Sclerosis (Bourneville's Disease) 12/2021 - 01/2020
2	Genomic Instability 01/2021 - 01/2020
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021 - 01/2020
2	Necrosis 01/2021 - 04/2017
2	Osteoarthritis 01/2021 - 04/2014
2	Ischemia 11/2020 - 01/2020

Drug/Important Bio-Agent (IBA)

24	Long Noncoding RNAIBA 01/2022 - 01/2011
20	Biomarkers (Surrogate Marker)IBA 03/2022 - 08/2015
14	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2013
13	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2011
12	Pharmaceutical PreparationsIBA 06/2022 - 01/2013
8	Biological ProductsIBA 06/2022 - 02/2016
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 10/2014
4	Transcription Factors (Transcription Factor)IBA 04/2022 - 01/2015
4	Ferritins (Ferritin)IBA 01/2022 - 01/2018
4	ApoferritinsIBA 01/2022 - 10/2014
4	Transferrin Receptors (Transferrin Receptor)IBA 01/2022 - 10/2014
4	Cell-Free Nucleic AcidsIBA 10/2021 - 01/2020
4	ProgranulinsIBA 01/2017 - 05/2015
3	AlkaloidsIBA 06/2022 - 01/2020
3	Matrix Metalloproteinases (MMPs)IBA 12/2020 - 01/2014
3	FurinIBA 08/2020 - 04/2017
3	Amyloid (Amyloid Fibrils)IBA 12/2016 - 04/2015
3	VaccinesIBA 04/2015 - 03/2012
3	AntigensIBA 04/2015 - 01/2013
2	LuciferasesIBA 12/2022 - 11/2021
2	ResveratrolIBA 12/2022 - 01/2021
2	AntioxidantsIBA 08/2022 - 01/2016
2	CollagenIBA 08/2022 - 01/2022
2	Epinephrine (Adrenaline)FDA LinkGeneric 08/2022 - 01/2022
2	Antineoplastic Agents (Antineoplastics)IBA 06/2022 - 01/2021
2	tetrandrineIBA 06/2022 - 01/2020
2	LipidsIBA 04/2022 - 12/2018
2	XELOXIBA 03/2022 - 10/2021
2	Chimeric Antigen ReceptorsIBA 02/2022 - 01/2020
2	Interleukin-6 (Interleukin 6)IBA 02/2022 - 02/2016
2	Mechanistic Target of Rapamycin Complex 1IBA 12/2021 - 01/2020
2	ErbB Receptors (EGF Receptor)IBA 12/2021 - 04/2017
2	TOR Serine-Threonine KinasesIBA 12/2021 - 01/2020
2	trans-sodium crocetinate (crocetin)IBA 12/2021 - 01/2020
2	MK 2206IBA 10/2021 - 11/2020
2	gadolinium ethoxybenzyl DTPA FDA Link 10/2021 - 01/2021
2	SolutionsIBA 09/2021 - 09/2019
2	hydrogen sulfite (bisulfite)IBA 08/2021 - 01/2021
2	Circular RNAIBA 01/2021 - 03/2020
2	Sorafenib (BAY 43-9006)FDA Link 01/2021 - 01/2019
2	HydrogelsIBA 01/2021 - 03/2012
2	InterferonsIBA 01/2021 - 10/2014
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2021
2	ChitosanIBA 01/2020 - 03/2012

Therapy/Procedure

22	Therapeutics 06/2022 - 01/2017
10	Drug Therapy (Chemotherapy) 06/2022 - 11/2014
10	Immunotherapy 01/2022 - 10/2014
7	Hematopoietic Stem Cell Transplantation 06/2022 - 06/2017
5	Precision Medicine 01/2022 - 03/2019
3	Transplantation 06/2022 - 04/2021
2	Intravenous Injections 01/2022 - 01/2013